References
- Carey R M. Dopamine, hypertension, and the potential for agonist therapy. Hypertension: Pathophysiology, Diagnosis, and Management 2nd edition, H J Laragh, M B Brenner. Raven Press, Ltd. 1995; 2937–2952
- Carey R M, Siragy H M, Ragsdale N V, Howell N L, Felder R A, Peach M J, Chevalier R L. Dopamine-1 and dopamine-2 mechanisms in the control of renal function. Am J Hypertens 1990; 3: 59S–63S
- Soares-da-Silva P. Source and handling of renal dopamine: its physiological importance. News Physiol Sci 1994; 9: 128–134
- Siragy H M, Carey R M. The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′,5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 1996; 97: 1978–1982
- Siragy H M, Howell N L, Ragsdale N V, Carey R M. Renal interstitial fluid angiotensinmodulation by anesthesia, epinephrine, sodium depletion and renin inhibition. Hypertension 1995; 25: 1021–1024
- Siragy H M, Linden J. Sodiumintake markedly alters renal interstitial fluid adenosine. Hypertension 1996; 27(part 1)404–407
- Siragy H M, Johns R A, Peach M J, Carey R M. Nitric oxide alters renal function and guanosine 3′,5′-monophosphate. Hypertension 1992; 19: 775–779
- Siragy H M, Jaffa A A, Margolius H S. Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens 1993; 6: 863–866
- Siragy H M, Ibrahim M M, Jaffa A A, Mayfield R, Margolius H S. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3′,5′-monophosphate: effects of altered sodium intake. Hypertension 1994; 23: 1068–1070
- Wang Z Q, Way D, Shimizu K, Fong F, Trigg L, McGrath B P. Beneficial acute effects of selective modulation of renal dopamine system by γ-L-glutamyl-L-dopa in rabbits with congestive heart failure. J Cardiovasc Pharmacol 1993; 21: 1004–1011
- Sarre S, Michotte Y. High-performance liquid chromatography with electrochemical detection for the determination of levodopa, catecholamines and their metabolites in rat brain dialysates. J Chromatogr 1992; 575: 207–212
- Ball S G, Gunn I G, Douglas I HS. Renal handling of dopa, norepinephrine, and epinephrine in the dog. Am J Physiol 1982; 242: F56–62.
- Stephenson R K, Sole M J, Baines A D. Neural and extraneural catecholamine production by rat kidneys. Am J Physiol 1982; 242: F261–266.
- Dawirs R, Teuchert-Noodt G. Demonstration of dopamine-immunoreactive cells in the proximal convoluted tubule of gerbil (Meriones unguiculatus) kidney. J Histochem Cytochem 1992; 40: 1685–1691
- Hagege J, Richet G. Proximal tubule dopamine histofluorescence in renal slices incubated with dopa. Kidney Int 1985; 27: 3–8
- Dawson R, Jr, Felheim R, Phillips M I. Characterization of the synthesis and release of dopamine in LLC-PK1 cells. Renal Physiol Biochem 1994; 17: 85–100
- Akama H, Noshiro T, Sano N, Watanabe T, Trigg L, Kotsonis P, Majewski H, McGrath B P, Miura Y, Abe K. Effects of isotonic saline loading on renal tubular and neurogenic dopamine release in conscious rabbits. Clin Exp Pharmacol Physiol 1995; 22: 469–471
- Wang Z Q, Shimizu K, Way D, Secombe J, McGrath B P. The dopamine prodrug, gludopa, decrease both renal and extrarenal noradrenaline spillover in conscious rabbits. Clin Exp Pharmacol Physiol 1993; 20: 365–368
- Morgunov N, Baines A D. Vagal afferent activity and renal release of dopamine. Can J Physiolo Pharmacol 1985; 63: 636–641
- Siragy H M, Felder R A, Howell N L, Chevalier R L, Peach M J, Carey R M. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 1989; 257: F469–F477
- Baines A D, Drangova R. Neural not tubular dopamine increases glomerular filtration rate in perfused rat kidneys. Am J Physiol 1986; 250: F674–F679